UltraClear
Skin renewal. Considered in detail.
Ablative fiber-laser resurfacing platform with multiple treatment modes for superficial to deeper rejuvenation.
Your medical assessment determines suitability.
- 012910 nm cold fiber laser
- 02High-precision ablative delivery
- 03Multiple treatment modules
Areas of application
Fine lines & wrinkles · Scars & acne scars · Tone, texture & age spots
An informed choice.
What the evidence can tell you — and where its limits matter.
Sources checkedEvidence & expectations
A 20-person study examined two superficial, low-fluence 2910 nm treatments for mild photodamage. It reported improvement with short-term skin effects. Evidence from that superficial mode cannot be transferred unchanged to deeper resurfacing or Laser-Coring.[1]
Preparation & recovery
Clarify the exact treatment mode and depth before arranging social or work commitments. The superficial study observed redness and swelling; more intensive modes need a separate discussion of wound care, recovery and review.[1][2]
Risks & limitations
Pigment can darken or lighten after an inflammatory procedure. Melasma can recur and needs an ongoing management plan; a laser is not a universal cure for brown patches. Establish the diagnosis before selecting the device.[3]
The word “cold” in a platform description does not mean there is no tissue injury. Ask specifically about infection, scarring, pigment alteration and the plan for an unexpected healing response.[2]
Compare your options
Compare the goal and recovery of superficial refreshment, fractional non-ablative treatment and deeper resurfacing. Greater treatment intensity is not automatically the better choice.[1][4]
Different approaches to discuss
These links explain different targets. They are not personalised recommendations.
3DMIRACLUltraClear Laser-CoringUltraMD skin renewalSources & further reading
- Clinical studyLow-fluence 2910 nm fiber laser for photodamageBernstein et al. · Lasers in Surgery and Medicine · 2023
- Professional guidanceLaser resurfacing for ageing skin: risks and recoveryAmerican Society for Dermatologic Surgery
- Professional guidanceMelasma: diagnosis and treatmentAmerican Academy of Dermatology
- Controlled clinical trialFractionated picosecond versus 1927 nm thulium laser: randomized trialWu et al. · Lasers in Surgery and Medicine · 2021
- Manufacturer informationUltraClear: platform informationAcclaroManufacturer information explains the platform or named protocol; it is not independent evidence of clinical benefit.
How we use evidence
A controlled trial compares interventions in defined groups; an uncontrolled cohort cannot, alone, establish causality. A review depends on the quality of its included studies. We distinguish these sources from manufacturer information and identify when findings do not directly apply to the platform or protocol.
The date records when sources were checked for this guide. It is not a statement of individual clinical review, product authorisation or confirmation of the clinic’s available configuration.
This guide supports a conversation with your clinician. It does not determine your suitability or replace individual aftercare instructions.
Where this technology fits.
Explore the treatment pathways that use this platform, including the sequence and what to discuss at your assessment.